0001209191-23-037201.txt : 20230614
0001209191-23-037201.hdr.sgml : 20230614
20230614194846
ACCESSION NUMBER: 0001209191-23-037201
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230612
FILED AS OF DATE: 20230614
DATE AS OF CHANGE: 20230614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Khan Amin
CENTRAL INDEX KEY: 0001908376
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40655
FILM NUMBER: 231015725
MAIL ADDRESS:
STREET 1: C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC
STREET 2: 200 BOSTON AVENUE, SUITE 3100
CITY: MEDFORD
STATE: MA
ZIP: 02155
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Icosavax, Inc.
CENTRAL INDEX KEY: 0001786255
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1930 BOREN AVE., SUITE 1000
CITY: SEATTLE
STATE: WA
ZIP: 98101
BUSINESS PHONE: (206) 737-0085
MAIL ADDRESS:
STREET 1: 1930 BOREN AVE., SUITE 1000
CITY: SEATTLE
STATE: WA
ZIP: 98101
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-12
0
0001786255
Icosavax, Inc.
ICVX
0001908376
Khan Amin
C/O ICOSAVAX, INC.
1930 BOREN AVE., SUITE 1000
SEATTLE
WA
98101
0
1
0
0
EVP, Head of Research & Dev.
0
Stock Option (Right to Buy)
10.16
2023-06-12
4
A
0
180000
0.00
A
2033-06-11
Common Stock
180000
180000
D
25% of the shares subject to the option will vest on June 12, 2024, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
/s/ Elizabeth Bekiroglu, Attorney-in-Fact
2023-06-14